Eyebright Medical Announces Strong First Half 2024 Results, with Revenue Surpassing 68% Growth and Net Profit Rising by Nearly 30%
- Written by PR Newswire
HONG KONG, Aug. 22, 2024 /PRNewswire/ -- Eyebright Medical Technology (Beijing) Ltd ('Eyebright Medical'; the 'Company'; SH Stock Code: 688050), the first domestic manufacturer of high-end refractive intraocular lenses in China, today announced its financial results for the first half of 2024.
The Company reported strong revenue growth, with total...














